Joseph E. Amegadzie

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The Financial Burden of Prescribed Medications in COPD.

The Financial Burden of Prescribed Medications in COPD.

Journal: CHEST pulmonary

Published: September 05, 2026

Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study.

Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study.

Journal: Thorax

Published: January 18, 2026

Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD.

Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD.

Journal: Thorax

Published: June 20, 2025

Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease.

Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease.

Journal: Annals of the American Thoracic Society

Published: June 20, 2025

20-year trends in excess costs of COPD.

20-year trends in excess costs of COPD.

Journal: The European respiratory journal

Published: March 14, 2024

Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada.

Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: July 19, 2023

A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk.

A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk.

Journal: The European respiratory journal

Published: July 11, 2023

QRISK3 underestimates the risk of cardiovascular events in patients with COPD.

QRISK3 underestimates the risk of cardiovascular events in patients with COPD.

Journal: Thorax

Published: June 21, 2023

The increasing burden of asthma acute care in Singapore: an update on 15-year population-level evidence.

The increasing burden of asthma acute care in Singapore: an update on 15-year population-level evidence.

Journal: BMC pulmonary medicine

Published: May 01, 2023

Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap.

Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap.

Journal: Respiratory research

Published: August 29, 2022

Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.

Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.

Journal: International journal of chronic obstructive pulmonary disease

Published: January 27, 2022

Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study.

Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study.

Journal: International journal of chronic obstructive pulmonary disease

Published: May 26, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026